CMPUY logo

CompuGroup Medical SE & Co. KGaA (CMPUY) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

CMPUY, $ (piyasa değeri 0) fiyatla Healthcare işi olan CompuGroup Medical SE & Co. KGaA'i temsil ediyor. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 48/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 16 Mar 2026
48/100 AI Puanı

CompuGroup Medical SE & Co. KGaA (CMPUY) Sağlık ve Boru Hattı Genel Bakışı

CEODaniel Gotthardt
Çalışanlar8299
MerkezKoblenz, DE
Halka Arz Yılı2012
SektörHealthcare

CompuGroup Medical SE & Co. KGaA, a German-based healthcare IT firm, delivers software and IT solutions across four segments: Ambulatory, Pharmacy, Hospital, and Consumer Health. With a global presence and a focus on digital healthcare solutions, the company supports healthcare providers and consumers, holding a significant position in the healthcare information services sector.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 16 Mar 2026

Yatırım Tezi

CompuGroup Medical SE & Co. KGaA presents a mixed investment thesis. The company's established presence in the healthcare IT sector and diverse product portfolio across ambulatory, pharmacy, hospital, and consumer health segments provide a stable revenue base. The company's P/E ratio is 89.71, and the profit margin is 1.5%. Growth catalysts include expanding digital health solutions and increasing demand for integrated healthcare systems. Potential risks include intense competition, evolving regulatory landscapes, and the relatively low profit margin. The company's beta of 0.82 suggests lower volatility compared to the market. The dividend yield is 0.22%.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • CompuGroup Medical operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS).
  • The company serves a global market, providing healthcare IT solutions to various healthcare providers and consumers.
  • CompuGroup Medical's gross margin stands at 83.6%, indicating strong pricing power and efficient cost management in its software and IT solutions.
  • The company's market capitalization is $1.19 billion, reflecting its significant presence in the healthcare IT sector.
  • CompuGroup Medical has a dividend yield of 0.22%, offering a modest income stream for investors.

Rakipler & Benzerleri

Güçlü Yönler

  • Comprehensive product portfolio across multiple healthcare segments.
  • Established presence in the European healthcare IT market.
  • Strong gross margin of 83.6%.
  • Focus on integrated healthcare solutions.

Zayıflıklar

  • Relatively low profit margin of 1.5%.
  • Dependence on regulatory compliance and healthcare policies.
  • Limited presence in some emerging markets.
  • High P/E ratio of 89.71.

Katalizörler

  • Ongoing: Increasing adoption of digital health solutions by healthcare providers and consumers.
  • Ongoing: Expansion of integrated healthcare systems and data analytics capabilities.
  • Upcoming: Potential strategic acquisitions to expand product offerings and market share.
  • Ongoing: Government initiatives promoting electronic health records and telehealth services.
  • Ongoing: Growing demand for IT security services in the healthcare sector.

Riskler

  • Potential: Intense competition from other healthcare IT providers.
  • Potential: Evolving regulatory landscape and compliance requirements.
  • Potential: Cybersecurity threats and data breaches.
  • Potential: Economic downturns affecting healthcare spending.
  • Ongoing: Currency risk associated with the ADR structure.

Büyüme Fırsatları

  • Expansion of Digital Health Solutions: CompuGroup Medical has the opportunity to expand its digital health solutions, including consumer portals and mobile apps. The digital health market is experiencing rapid growth, driven by increasing consumer demand for convenient and accessible healthcare services. By enhancing its digital offerings, CompuGroup Medical can attract new customers and increase revenue. The global digital health market is projected to reach $660 billion by 2025, presenting a substantial growth opportunity for the company.
  • Integration of Healthcare Systems: The increasing demand for integrated healthcare systems presents a significant growth opportunity for CompuGroup Medical. Healthcare providers are seeking solutions that can seamlessly integrate data across different systems, improving efficiency and patient care. CompuGroup Medical can capitalize on this trend by developing and offering integrated solutions that connect ambulatory, pharmacy, hospital, and consumer health systems. This integration can lead to increased customer loyalty and higher revenue.
  • Geographic Expansion: CompuGroup Medical can pursue geographic expansion to tap into new markets and increase its global presence. Emerging markets, in particular, offer significant growth potential due to increasing healthcare spending and the adoption of digital health technologies. By expanding into these markets, CompuGroup Medical can diversify its revenue streams and reduce its reliance on mature markets. This expansion requires careful market analysis and strategic partnerships to navigate local regulations and cultural differences.
  • Strategic Acquisitions: CompuGroup Medical can pursue strategic acquisitions to expand its product portfolio and market share. Acquiring companies with complementary technologies or customer bases can accelerate growth and enhance the company's competitive position. Potential acquisition targets include companies specializing in telehealth, data analytics, or cybersecurity for healthcare providers. These acquisitions should be carefully evaluated to ensure they align with CompuGroup Medical's overall strategy and create synergies.
  • Data Analytics and AI: CompuGroup Medical can leverage data analytics and artificial intelligence (AI) to improve its products and services. By analyzing healthcare data, the company can identify trends, predict patient outcomes, and personalize treatment plans. AI can also be used to automate tasks, improve efficiency, and reduce costs. Investing in data analytics and AI capabilities can enhance CompuGroup Medical's competitive advantage and drive innovation in the healthcare IT sector. The market for AI in healthcare is expected to reach $34 billion by 2025.

Fırsatlar

  • Expansion into new geographic markets.
  • Growth in the digital health solutions market.
  • Strategic acquisitions to expand product offerings.
  • Increased demand for integrated healthcare systems.

Tehditler

  • Intense competition from other healthcare IT providers.
  • Evolving regulatory landscape and compliance requirements.
  • Cybersecurity threats and data breaches.
  • Economic downturns affecting healthcare spending.

Rekabet Avantajları

  • Established Customer Base: Long-standing relationships with a diverse customer base in the healthcare sector.
  • Integrated Solutions: Comprehensive suite of integrated software solutions across ambulatory, pharmacy, hospital, and consumer health segments.
  • Regulatory Expertise: Deep understanding of healthcare regulations and compliance requirements.
  • Data Assets: Proprietary data assets and analytics capabilities that provide valuable insights to customers.

CMPUY Hakkında

CompuGroup Medical SE & Co. KGaA, founded in 1987 and headquartered in Koblenz, Germany, develops and sells software and IT solutions for the healthcare sector globally. The company operates through four key segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment offers practice management software and electronic medical records for physicians and medical centers, along with supplementary internet solutions. The PCS segment provides software applications for pharmacies, focusing on administrative and billing processes, and offers decision support for medication supply chain management. The HIS segment delivers clinical and administrative solutions for hospitals, rehabilitation centers, and medical laboratories. The CHS segment provides IT security services, data-based product offerings, software interfaces, and clinical decision-making support for healthcare providers, as well as digital healthcare platforms and mobile apps for consumers. CompuGroup Medical serves a diverse clientele, including pharmaceutical companies, health insurance companies, and individual consumers. Formerly known as CompuGroup Medical SE, the company rebranded in June 2020 to CompuGroup Medical SE & Co. KGaA, reflecting its continued evolution in the healthcare IT landscape.

Ne Yaparlar

  • Develops and sells software for ambulatory information systems (AIS).
  • Provides software solutions for pharmacy information systems (PCS).
  • Offers clinical and administrative solutions for hospital information systems (HIS).
  • Creates consumer and health management information systems (CHS).
  • Delivers IT security services for healthcare providers.
  • Provides data-based product offers and software interfaces for information sharing.
  • Offers clinical decision-making support and medication databases.
  • Develops digital healthcare stock, consumer portals, and mobile apps.

İş Modeli

  • Software Licensing: Generates revenue through licensing its software solutions to healthcare providers and pharmacies.
  • Subscription Services: Offers subscription-based services for ongoing access to its software and related support.
  • IT Services: Provides IT security services and data-based product offers to healthcare organizations.
  • Data Analytics: Leverages healthcare data to provide insights and analytics to improve patient outcomes and efficiency.

Sektör Bağlamı

CompuGroup Medical operates in the rapidly evolving healthcare IT sector. The industry is driven by increasing demand for digital health solutions, electronic health records, and integrated healthcare systems. The market is competitive, with key players including BITGF (Allscripts Healthcare Solutions), BTTAY (Cerner), CSWYF (Change Healthcare), DGWPF (Teladoc Health), and DWRKF (athenahealth). These companies compete on product offerings, technological innovation, and market reach. The healthcare IT market is expected to continue growing, fueled by government initiatives promoting electronic health records and the increasing adoption of telehealth services.

Kilit Müşteriler

  • Registered physicians and medical care centers.
  • Pharmacies and pharmaceutical companies.
  • Acute care hospitals and rehabilitation centers.
  • Health insurance companies.
  • Consumers seeking digital health solutions.
AI Güveni: 71% Güncellendi: 16 Mar 2026

Finansallar

Grafik & Bilgi

CompuGroup Medical SE & Co. KGaA (CMPUY) hisse senedi fiyatı: Price data unavailable

Son Haberler

CMPUY için son haber bulunmamaktadır.

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

CMPUY için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

CMPUY için Wall Street fiyat hedefi analizi.

MoonshotScore

48/100

Bu puan ne anlama geliyor?

MoonshotScore, CMPUY'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Daniel Gotthardt

Unknown

Information on Daniel Gotthardt's background is not available in the provided data. Therefore, a detailed career history, education, and previous roles cannot be provided. His experience prior to managing 8299 employees at CompuGroup Medical SE & Co. KGaA is Unknown.

Sicil: Due to the limited information available, Daniel Gotthardt's key achievements, strategic decisions, and company milestones under his leadership cannot be detailed. His specific contributions to CompuGroup Medical SE & Co. KGaA's performance are Unknown.

CompuGroup Medical SE & Co. KGaA ADR Bilgileri Sponsorsuz

An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. CMPUY is an ADR representing shares of CompuGroup Medical SE & Co. KGaA, a German company. This allows U.S. investors to invest in the company without directly dealing with foreign exchanges.

  • Ana Piyasa Sembolü: Frankfurt Stock Exchange, Germany
  • ADR Seviyesi: 1
  • ADR Oranı: 1:1
  • Ana Piyasa Sembolü: CMPU
Kur Riski: As an ADR, CMPUY is subject to currency risk. The value of the ADR can be affected by fluctuations in the exchange rate between the U.S. dollar and the Euro. If the Euro weakens against the dollar, the value of CMPUY in dollar terms may decrease, impacting returns for U.S. investors.
Vergi Etkileri: Dividends paid on CMPUY are subject to foreign dividend withholding tax in Germany. The standard withholding tax rate is Unknown, but this may be reduced by tax treaties between the U.S. and Germany. U.S. investors may be able to claim a foreign tax credit on their U.S. tax return for the amount of foreign tax withheld.
İşlem Saatleri: Trading hours for CMPUY in the U.S. market may differ from the trading hours of the home market (Frankfurt Stock Exchange). The Frankfurt Stock Exchange typically operates from 9:00 AM to 5:30 PM Central European Time (CET), while U.S. markets operate from 9:30 AM to 4:00 PM Eastern Time (ET). This difference in trading hours can affect the timing of price movements and trading opportunities.

CMPUY OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that CompuGroup Medical SE & Co. KGaA has limited regulatory requirements and reporting standards compared to companies listed on major exchanges like the NYSE or NASDAQ. Companies on this tier may not be required to file regular financial reports with the SEC, leading to less transparency for investors. Investing in OTC Other stocks carries higher risks due to the limited information available.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Liquidity for CMPUY on the OTC market is likely to be limited. OTC stocks generally have lower trading volumes and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more difficult to buy or sell shares quickly and at a favorable price. Investors should be prepared for potential price volatility and illiquidity when trading CMPUY.
OTC Risk Faktörleri:
  • Limited Transparency: OTC stocks often have limited financial disclosure, making it difficult to assess their true value and financial health.
  • Low Liquidity: Trading volumes can be thin, leading to wider bid-ask spreads and difficulty in executing large trades.
  • Price Volatility: OTC stocks can be more susceptible to price manipulation and volatility due to lower trading volumes.
  • Regulatory Risks: OTC companies may not be subject to the same level of regulatory scrutiny as exchange-listed companies.
  • Information Asymmetry: Limited access to information can create an uneven playing field for investors.
Durum Tespiti Kontrol Listesi:
  • Verify the company's registration and legal status.
  • Review available financial statements and disclosures.
  • Assess the company's business model and competitive landscape.
  • Evaluate the management team and their track record.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before investing.
  • Monitor the company's news and announcements for any updates.
Meşruiyet Sinyalleri:
  • Established Business Operations: CompuGroup Medical SE & Co. KGaA has been in operation since 1987, indicating a long-standing presence in the healthcare IT sector.
  • Global Presence: The company operates worldwide, serving various healthcare providers and consumers.
  • Diverse Product Portfolio: CompuGroup Medical offers a comprehensive suite of software and IT solutions across multiple healthcare segments.
  • ADR Listing: The existence of an ADR, even at Level I, suggests some level of compliance and oversight.

CMPUY Healthcare Hisse Senedi SSS

CMPUY için değerlendirilmesi gereken temel faktörler nelerdir?

CompuGroup Medical SE & Co. KGaA (CMPUY) şu anda yapay zeka skoru 48/100, düşük puanı gösteriyor. Temel güçlü yan: Comprehensive product portfolio across multiple healthcare segments.. İzlenmesi gereken birincil risk: Potential: Intense competition from other healthcare IT providers.. Bu bir finansal tavsiye değildir.

CMPUY MoonshotScore'u nedir?

CMPUY şu anda MoonshotScore'da 48/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

CMPUY verileri ne sıklıkla güncellenir?

CMPUY fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler CMPUY hakkında ne diyor?

CMPUY için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

CMPUY'a yatırım yapmanın riskleri nelerdir?

CMPUY için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Intense competition from other healthcare IT providers.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

CMPUY'ın P/E oranı nedir?

CMPUY için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için CMPUY'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

CMPUY aşırı değerli mi, yoksa düşük değerli mi?

CompuGroup Medical SE & Co. KGaA (CMPUY)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

CMPUY'ın temettü verimi nedir?

CompuGroup Medical SE & Co. KGaA (CMPUY) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Information is based on available data as of 2026-03-16.
  • AI analysis pending for CMPUY, which may provide further insights.
  • OTC market data may be limited and less reliable than exchange-listed data.
Veri Kaynakları

Popüler Hisseler